نتایج جستجو برای: cachexia

تعداد نتایج: 3974  

Journal: :The Proceedings of the Nutrition Society 2015
Jane B Hopkinson

Cancer cachexia is a complex syndrome. Its defining feature is involuntary weight loss, which arises, in part, because of muscle atrophy and is accompanied by functional decline. International expert consensus recommends that nutritional support and counselling is a component of multimodal therapy for cancer cachexia, as poor nutritional intake can contribute to progression of the syndrome. The...

Journal: :Infection and immunity 1988
C L Silva L H Faccioli

The mechanism by which cord factor (CF), a toxic glycolipid from mycobacteria, induces cachexia was studied in BALB/c mice. Body weight was markedly reduced 48 h after CF administration; the animals became severely wasted and exhibited hypertriglyceridemia, hypoglycemia, and high levels of tumor necrosis factor (TNF) in plasma. After CF administration, a transferable factor which caused cachexi...

2016
Suna Aydin

Cardiac cachexia, a syndrome characterized by systemic destruction, nutritional impairment and weight loss [1], has a prevalence ranging between 8 and 42% around the world [2]. The syndrome was first described by the father of medicine, Hippocrates, as follows: “the flesh is consumed and becomes water; shoulders, clavicles, chest and thighs melt away. The illness is fatal” [3]. Currently the mo...

2015
Josep M. Argilés Britta Stemmler Francisco J. López-Soriano Silvia Busquets

Cachexia is a syndrome associated with cancer, characterized by body weight loss, muscle and adipose tissue wasting, and inflammation, being often associated with anorexia. In spite of the fact that muscle tissue represents more than 40% of body weight and seems to be the main tissue involved in the wasting that occurs during cachexia, recent developments suggest that tissues/organs such as adi...

Journal: :British Journal of Surgery 2023

Abstract Introduction Cancer cachexia is associated with poor surgical outcomes, including increased length of stay, morbidity and mortality. Cachexia a complex multi-faceted pathological process consistently energy imbalance via hypermetabolism. Beyond this, pre-clinical animal models suggest mitochondrial dysfunction to be an important component cachexia, although this unconfirmed in humans. ...

2014
Abolfazl Avan Amir Avan Tessa Y. S. Le Large Andrea Mambrini Niccola Funel Mina Maftouh Majid Ghayour-Mobarhan Maurizio Cantore Ugo Boggi Godefridus J. Peters Paola Pacetti Elisa Giovannetti Francisco X. Real

Pancreatic ductal adenocarcinoma (PDAC) patients have the highest risk of developing cachexia, which is a direct cause of reduced quality of life and shorter survival. Novel biomarkers to identify patients at risk of cachexia are needed and might have a substantial impact on clinical management. Here we investigated the prognostic value and association of SELP-rs6136, IL6-rs1800796 and AKT1-rs1...

2016
Andrea Bonetto Joshua K. Kays Valorie A. Parker Ryan R. Matthews Rafael Barreto Melissa J. Puppa Kyung S. Kang James A. Carson Theresa A. Guise Khalid S. Mohammad Alexander G. Robling Marion E. Couch Leonidas G. Koniaris Teresa A. Zimmers

Cachexia is a distinctive feature of colorectal cancer associated with body weight loss and progressive muscle wasting. Several mechanisms responsible for muscle and fat wasting have been identified, however it is not known whether the physiologic and molecular crosstalk between muscle and bone tissue may also contribute to the cachectic phenotype in cancer patients. The purpose of this study w...

2017
H Alexander Ebhardt Simone Degen Valentina Tadini Alain Schilb Neil Johns Carolyn A Greig Kenneth C H Fearon Ruedi Aebersold Carsten Jacobi

BACKGROUND Cancer cachexia (cancer-induced muscle wasting) is found in a subgroup of cancer patients leaving the patients with a poor prognosis for survival due to a lower tolerance of the chemotherapeutic drug. The cause of the muscle wasting in these patients is not fully understood, and no predictive biomarker exists to identify these patients early on. Skeletal muscle loss is an inevitable ...

2016
Greetje Vanhoutte Mick van de Wiel Kristin Wouters Michaël Sels Linda Bartolomeeussen Sven De Keersmaecker Caroline Verschueren Veronique De Vroey Annemieke De Wilde Elke Smits Kin Jip Cheung Liesbeth De Clerck Petra Aerts Didier Baert Caroline Vandoninck Sofie Kindt Sofie Schelfhaut Marc Vankerkhoven Annelies Troch Lore Ceulemans Hanne Vandenbergh Sven Leys Tim Rondou Elke Dewitte Kristel Maes Patrick Pauwels Benedicte De Winter Luc Van Gaal Dirk Ysebaert Marc Peeters

OBJECTIVE This study aimed to provide evidence-based results on differences in overall survival (OS) rate to guide the diagnosis of cancer cachexia. DESIGN Data collection and clinical assessment was performed every 3 months (5 visits): baseline data, muscle strength, nutritional and psychosocial status. 2 definitions on cachexia using different diagnostic criteria were applied for the same p...

Journal: :Rheumatology 2008
G D Summers C M Deighton M J Rennie A H Booth

Rheumatoid cachexia is under-recognized in clinical practice. The loss of lean body tissue, which characterizes cachexia, is often compensated for by gain in body fat-so called 'cachectic obesity'-so that 85% or more RA patients have a normal BMI. Severe cachexia with loss of weight leads to increased morbidity and premature mortality but loss of muscle bulk with a normal BMI also associates wi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید